Cargando…

COVID-19 and Pre-existing Type 2 Diabetes Mellitus: A Retrospective Observational Study From Eastern India on the Association Between Glycaemic Control and Treatment Outcomes

Background: Diabetes has emerged as an important risk factor for causing severe illness and death from COVID-19. There is a paucity of structured data from the Indian subcontinent on the impact that glycaemic control (both immediate and remote) has on the degree of required medical intervention and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherjee, Poulomi, RoyChaudhuri, Soumyabrata, Majumder, Anirban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030157/
https://www.ncbi.nlm.nih.gov/pubmed/36960253
http://dx.doi.org/10.7759/cureus.35165
_version_ 1784910293673967616
author Mukherjee, Poulomi
RoyChaudhuri, Soumyabrata
Majumder, Anirban
author_facet Mukherjee, Poulomi
RoyChaudhuri, Soumyabrata
Majumder, Anirban
author_sort Mukherjee, Poulomi
collection PubMed
description Background: Diabetes has emerged as an important risk factor for causing severe illness and death from COVID-19. There is a paucity of structured data from the Indian subcontinent on the impact that glycaemic control (both immediate and remote) has on the degree of required medical intervention and mortality among hospitalized COVID-19 patients with type 2 diabetes mellitus (T2DM). Objectives: To evaluate the differences in clinical characteristics and treatment outcomes between well-controlled and poorly controlled patients with T2DM and COVID-19. Methods: This was a retrospective observational study. Data on 177 patients who were hospitalized between February 2021 and July 2021 were categorized into four groups using a cut-off admission plasma glucose of <200 mg/dL and glycated hemoglobin (HbA1c) <7.5%. Results: Patients with poorly controlled diabetes presented at a significantly older age than the other groups. Radiological findings suggested severe lung involvement in them. As a combined group patients with HbA1c ≥7.5% required more ventilatory requirement as compared with the group having HbA1c <7.5% irrespective of admission glucose. They also required prolonged hospitalization and intensive care unit (ICU) stays as compared with the well-controlled diabetes group. In this study, within similar ranges of HbA1c admission glucose seemed to have a numerical impact on mortality without being able to achieve statistical significance. Conclusion: From the current study, it can be concluded that poor glycaemic control, particularly HbA1c ≥7.5%, is an important risk factor for the development of severe COVID-19 and a predictor for the requirement of more intensive treatment and adverse treatment outcomes leading to increased hospital and ICU stay.
format Online
Article
Text
id pubmed-10030157
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-100301572023-03-22 COVID-19 and Pre-existing Type 2 Diabetes Mellitus: A Retrospective Observational Study From Eastern India on the Association Between Glycaemic Control and Treatment Outcomes Mukherjee, Poulomi RoyChaudhuri, Soumyabrata Majumder, Anirban Cureus Endocrinology/Diabetes/Metabolism Background: Diabetes has emerged as an important risk factor for causing severe illness and death from COVID-19. There is a paucity of structured data from the Indian subcontinent on the impact that glycaemic control (both immediate and remote) has on the degree of required medical intervention and mortality among hospitalized COVID-19 patients with type 2 diabetes mellitus (T2DM). Objectives: To evaluate the differences in clinical characteristics and treatment outcomes between well-controlled and poorly controlled patients with T2DM and COVID-19. Methods: This was a retrospective observational study. Data on 177 patients who were hospitalized between February 2021 and July 2021 were categorized into four groups using a cut-off admission plasma glucose of <200 mg/dL and glycated hemoglobin (HbA1c) <7.5%. Results: Patients with poorly controlled diabetes presented at a significantly older age than the other groups. Radiological findings suggested severe lung involvement in them. As a combined group patients with HbA1c ≥7.5% required more ventilatory requirement as compared with the group having HbA1c <7.5% irrespective of admission glucose. They also required prolonged hospitalization and intensive care unit (ICU) stays as compared with the well-controlled diabetes group. In this study, within similar ranges of HbA1c admission glucose seemed to have a numerical impact on mortality without being able to achieve statistical significance. Conclusion: From the current study, it can be concluded that poor glycaemic control, particularly HbA1c ≥7.5%, is an important risk factor for the development of severe COVID-19 and a predictor for the requirement of more intensive treatment and adverse treatment outcomes leading to increased hospital and ICU stay. Cureus 2023-02-19 /pmc/articles/PMC10030157/ /pubmed/36960253 http://dx.doi.org/10.7759/cureus.35165 Text en Copyright © 2023, Mukherjee et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Mukherjee, Poulomi
RoyChaudhuri, Soumyabrata
Majumder, Anirban
COVID-19 and Pre-existing Type 2 Diabetes Mellitus: A Retrospective Observational Study From Eastern India on the Association Between Glycaemic Control and Treatment Outcomes
title COVID-19 and Pre-existing Type 2 Diabetes Mellitus: A Retrospective Observational Study From Eastern India on the Association Between Glycaemic Control and Treatment Outcomes
title_full COVID-19 and Pre-existing Type 2 Diabetes Mellitus: A Retrospective Observational Study From Eastern India on the Association Between Glycaemic Control and Treatment Outcomes
title_fullStr COVID-19 and Pre-existing Type 2 Diabetes Mellitus: A Retrospective Observational Study From Eastern India on the Association Between Glycaemic Control and Treatment Outcomes
title_full_unstemmed COVID-19 and Pre-existing Type 2 Diabetes Mellitus: A Retrospective Observational Study From Eastern India on the Association Between Glycaemic Control and Treatment Outcomes
title_short COVID-19 and Pre-existing Type 2 Diabetes Mellitus: A Retrospective Observational Study From Eastern India on the Association Between Glycaemic Control and Treatment Outcomes
title_sort covid-19 and pre-existing type 2 diabetes mellitus: a retrospective observational study from eastern india on the association between glycaemic control and treatment outcomes
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030157/
https://www.ncbi.nlm.nih.gov/pubmed/36960253
http://dx.doi.org/10.7759/cureus.35165
work_keys_str_mv AT mukherjeepoulomi covid19andpreexistingtype2diabetesmellitusaretrospectiveobservationalstudyfromeasternindiaontheassociationbetweenglycaemiccontrolandtreatmentoutcomes
AT roychaudhurisoumyabrata covid19andpreexistingtype2diabetesmellitusaretrospectiveobservationalstudyfromeasternindiaontheassociationbetweenglycaemiccontrolandtreatmentoutcomes
AT majumderanirban covid19andpreexistingtype2diabetesmellitusaretrospectiveobservationalstudyfromeasternindiaontheassociationbetweenglycaemiccontrolandtreatmentoutcomes